Dror Bashan insider trades
Open-market stock purchases and sales by Dror Bashan, PRESIDENT AND CEO at Protalix BioTherapeutics, Inc, from SEC Form 4 filings since Jun 30, 2019.
Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +70%.
Companies traded
- PLX Protalix BioTherapeutics, Inc: 4 buys, last Sep 3, 2026